Publication:
Histone Deacetylase 6 at Crossroads of Invection and Innate Immunity

dc.contributor.advisorSanchez-Madrid, Francisco
dc.contributor.authorMoreno-Gonzalo, Olga
dc.contributor.funderMinisterio de Economía y Competitividad (España)
dc.contributor.funderComunidad de Madrid (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderUnión Europea. Comisión Europea
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)
dc.contributor.funderFundación ProCNIC
dc.contributor.funderMinisterio de Educación (España)
dc.date.accessioned2019-06-05T12:45:55Z
dc.date.available2019-06-05T12:45:55Z
dc.date.issued2018-05-25
dc.description.abstractRecent evidence on Histone deacetyase 6 (HDAC6) function underlines its role as a key protein in the innate immune response to viral infection. However, whether HDAC6 regulates innate immunity during bacterial infection remains unexplored. To assess the role of HDAC6 in the regulation of defence mechanisms against intracellular bacteria, we used the Listeria monocytogenes (Lm) infection model. Here we describe that in the absence of HDAC6 Granulocyte/Macrophage colony stimulating factorderived dendritic cells (GM‐CSF DCs) display higher intracellular bacterial titres than their wild type (wt) counterparts. The impaired bacterial clearance appears to be caused by a defect in autophagy. This correlates with an increase in the accumulation of the autophagy marker p62 in Hdac6‐/‐ DCs, due to a defective phagosome‐lysosome fusion. We also identify higher levels of acetylated cortactin colocalizing with intracellular bacteria in Hdac6‐/‐ DCs compared to wt, suggesting that this Posttranslational modification (PTM) in cortactin could delay the phagosome‐lysosome fusion. Additionally, a lower expression of interferon‐related genes and pro‐inflammatory cytokines is detected in Hdac6‐/‐ DCs after Lm infection. This observation is in accordance with lower nitrite production and inducible nitric oxide synthase (iNOS) induction during bacterial infection in Hdac6‐/DCs. Likewise, phosphorylation of Mitogen‐activated protein kinase (MAPK) and mammalian target of rapamycin (mTOR) signalling pathways is reduced in Hdac6‐/‐ DCs in response to Lm, suggesting an altered Toll‐like receptor response to Lm and various TLR agonists is detected in both Hdac6‐/‐ GM‐CSF‐derived and FMS‐like tyrosine kinase 3 (FLT3L)‐derived dendritic cells. Interestingly, our data reveal the molecular association of HDAC6 with the TLR‐adaptor protein Myeloid differentiation primary response gene 88 (MyD88), and how the absence of HDAC6 seems to diminish Nuclear factor κB (NF‐κB) induction after TLR stimuli. Moreover, Hdac6‐/‐ mice display low serum levels of the inflammatory cytokine IL‐6 and correspondingly an increased survival to a systemic infection with a lethal dose of Lm. These data underline the important function of HDAC6 in DCs, not only in the control of bacterial burden through degradation by autophagy, but also in the proper activation of TLR signalling. These results thus underscore an important regulatory role for HDAC6 in almost every step of DC functions against intracellular bacterial infection, highlithing HDAC6 as a new player of innate immune responses. (TLR) signalling. A defective pro‐inflammatory cytokine production ines_ES
dc.description.sponsorshipThis work has been performed at the Prof. Francisco Sánchez‐Madrid’s laboratory in the Hospital Universitario de la Princesa (HUP) and Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid. This study was funded by grants SAF2014‐55579‐R from the Spanish Ministry of Economy and Competitiveness, INDISNET‐S2011/ BMD‐2332 from the Comunidad de Madrid, CIBERCARDIOVASCULAR and grant PIE13/00041 from the Instituto de Salud Carlos III (Fondo de Investigación Sanitaria del Instituto de Salud Carlos III with co‐funding from the Fondo Europeo de Desarrollo Regional; FEDER), and ERC‐2011‐AdG 294340‐ GENTRIS and COST‐Action BM1202 from the European Comission to Francisco SánchezMadrid. The Centro Nacional de Investigaciones Cardiovasculares (CNIC) is supported by the Spanish Ministry of Economy and Competitiveness (MINECO) and the Pro‐CNIC Foundation and is a Severo Ochoa Center of Excellence (MINECO award SEV‐2015‐0505). Olga Moreno was supported by a PhD fellowship from the Spanish Ministry of Education (FPU Program, FPU12/00733). We thank Dr. M. Gómez for assitance with English editing and for critical reading of this PhD thesis.es_ES
dc.identifier.doi10.4321/repisalud.7741
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7741
dc.language.isoenges_ES
dc.publisherUniversidad Autónoma de Madrid (UAM) (España)es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2014-55579-Res_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PIE/2013-00041es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/294340/EUes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SEV-2015-0505es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/FPU12/00733es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Comunicación Intercelular en la Respuesta Inflamatoriaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleHistone Deacetylase 6 at Crossroads of Invection and Innate Immunityes_ES
dc.typedoctoral thesises_ES
dspace.entity.typePublication
relation.isAdvisorOfPublication51eb6cbc-309f-4845-987e-5b2cea239c59
relation.isAdvisorOfPublication.latestForDiscovery51eb6cbc-309f-4845-987e-5b2cea239c59
relation.isAuthorOfPublication091a9252-7193-412e-897e-52d12912d5fb
relation.isAuthorOfPublication.latestForDiscovery091a9252-7193-412e-897e-52d12912d5fb

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Olga_Moreno.pdf
Size:
48.32 MB
Format:
Adobe Portable Document Format
Description: